Anika Therapeutics Inc. (ANIK)

[surf1944]

Companies that are currently slated for FDA 501(k) decisions before 6/30/12 include: Anika Therapeutics (ANIK), Given Imaging (GIVN), and Hansen Medical (HNSN). These three companies are all small cap as well with market capitalizations of $120M, $539M, and $135M, respectively.

As mentioned, the Biotech Catalyst Strategy is most effective for stocks with poor price momentum. Ranking the six candidate stocks by their S&P Relative Strength rankings, ECTE has the lowest ranking of (12), followed by HNSN (16), GPRO (59), GIVN (81), and ANIK (95).

http://seekingalpha.com/article/319387-biotechnology-fda-approval-catalyst-strategy?source=yahoo